<DOC>
	<DOCNO>NCT01524939</DOCNO>
	<brief_summary>The purpose study evaluate safety , efficacy Immune Globulin Intravenous ( Human ) IVIG-SN™ subject kawasaki disease .</brief_summary>
	<brief_title>Study Combined Therapy Aspirin `` IVIG-SN '' Kawasaki Disease</brief_title>
	<detailed_description>This clinical trial design multicenter , single-arm , open-label clinical trial . Evaluate incidence coronary artery lesion 7th week IVIG-SN administration , compare incidence coronary artery lesion among untreated Kawasaki patient , prove superior efficacy IVIG-SN .</detailed_description>
	<mesh_term>Mucocutaneous Lymph Node Syndrome</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>1 . Pediatric patient age 6 month 5 year 2 . Case definition complete KD : Fever ( ≥ 38.5°C ) ≥ 5 day ( less 10 day ) , 4/5 standard clinical criterion 3 . Case definition incomplete KD : Fever ≥ 5 day ( less 10 day ) 3 clinical criterion plus coronary artery lesion echocardiogram . 4 . Subjects whose parent legally acceptable representative ( LAR ) give voluntary write consent participate clinical trial 1 . Those whose blood test result show abnormalities significance follow : Platelet count &lt; 100,000/mm3 , WBC count &lt; 3,000 cells/mm3 , Those whose hemogloblin , hematocrit red blood cell count exceed 30 % upper limit normal range 30 % low limit normal range . 2 . Those administered clinical product last 30 day clinical trial commence 3 . Those administered TNF alpha steroid within 48 hour administer test product 4 . Those plan inoculate live vaccine clincial trial period 5 . Those consider difficult participate clinical trial due serious chronic disease ( e.g. , cardiovascular disease except controllable hypertension , diseases respiratory system concurrent respiratory failure , metabolic disease , kidney dysfunction , hemoglobinopathy , etc . ) 6 . Those administered immunosuppressant immune modify drug last 3 month innoculation test product 7 . Those HIVpositive immune dysfunction include immunodeficiency 8 . Those previously exhibit hypersensitivity shock IVIG agents 9 . Patients underlie liver disease liver dysfunction know etiology . 10 . Patients kidney dysfunction , whose Creatinine level find 2 time high upper limit normal range screen test 11 . Those previously malignant tumor 12 . Those previously diagnose IgA deficiency 13 . Those find unsuitable undergoing test</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>